ReviewExpert review of clinical pharmacology2020

Cognitive impairment with diabetes mellitus and metabolic disease: innovative insights with the mechanistic target of rapamycin and circadian clock gene pathways.

Kenneth MaiesePubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.